Wiley Matthew T. - Insider Non-Derivative Transactions at BioXcel Therapeutics, Inc. (BTAI) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Sep 16, 2024, Wiley Matthew T.'s relationship to BioXcel Therapeutics, Inc. (BTAI) is Officer (Chief Commercial Officer), and currently has 4,033 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other BTAI insiders.
Data Source: SEC.
Wiley Matthew T. - Insider Non-Derivative Transactions of BTAI Common Stock
Wiley Matthew T. - Insider Non-Derivative Transactions at BTAI
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Sep 17, 2024 | Sell -- (Common Stock) | 215 | 0.69 | 4033 |
| Sep 16, 2024 | M -- (Common Stock) | 750 | 0 | 4248 |
| Jun 18, 2024 | Sell -- (Common Stock) | 244 | 1.26 | 3498 |
| Jun 16, 2024 | M -- (Common Stock) | 750 | 0 | 3742 |
| Apr 5, 2024 | Sell -- (Common Stock) | 1008 | 2.64 | 2992 |
| Mar 16, 2024 | M -- (Common Stock) | 3000 | 0 | 3000 |